Klip A,LeiterLA. A .1990 .Cellular mechanism of action of metformin. Diabetes Care, 13 : 696-704.
.1992 .Biguanides and NIDDM. Diabetes Care, 15(16) : 755-72.
.1972 .FredricksoDnS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparativeultracentrifuge. CHnChem, 18 : 499-502.
DeLong DM,DeLong ER,Wood PD .1986 .A comparisonof methods forthe estimation of plasma low and very-lowdensity lipoproteincholesterol. JAMA, 256(17) : 2372-7.
Ambrosi F .1990 .Low dose metformin in the treatment of type II non-insulindependent diabetes: clinical and metabolic evaluation. Acta Diabeto!Lat, 27 : 139-55.
TurnerRO. The UK Prospective Diabetes Study .1998 .C 35-8. Diabetes Care, 21(suppl3) : .
Zammam HY .1997 .Disparateeffects of antidiabetic drugson arteriaclontraction. Metabolism, 46(10) : 1199-205.
.1994 .comparisonof metforminand sulfonylurea,alone and in various combinations, A double blind controlled study. Diabetes Care, 17 : 1100-1109.
.1992 .Biguanides and. NIDDM. Diabetes Care, 15 : 755-72.
KaplanNM .1989 .The deadly quart. Upper-body obesity, glucose intolerance, hypertriglyceridemiand hypertension. Arch intern Med, 149 : 1514-20.
.1987 .ReavenGM and HoffmanD. A role for insulin in the etiology and course of hypertension. Lancet, : 435-7.
MbanyaJ-CN ,Thomas TH .1988 .hyperinsulinemia: a relation in diabetes but not essential hypertension. Lancet, 1 : 733-4.
ElkelesRS. .1988 .The effects of glibenclamide and metformin on serum lipoproteins in type 2 diabetes. Diabet Med, 5 : 653-8.
.1993 .-treated diabetic patients: improvement in glycemic control and reduction of metabolic risk factors. EurJdin Pharmacol, 44 : 107-112.
Wu MS,Sheu WH . .. Therapeutic, 20 : .
Chen YD .1990 .ReavenGM. Effect of metformin enhances acute depressorresponsesto metformin. Diabetes Care, 13(12 Pt1-2) : 1-8.
ElkelesRS. .1989 .metformin is maintained with long-term therapy. JRSocMed, 82 : 93-4.
Nagi DK,YudkinJS. DK .1993 .Effects of metformin on insulin resistanceriskfactorsforcardiovasculardisease, and plasminogen activator inhibitorin NIDDM subjects: a study of two ethnic groups. Diabetes Care, 16 : 621-9.